The PALB2 variant conferred a risk increase for breast cancer with a HR of 4.99 (95% CI 4.02–6.20, p = 6.76 × 10−48), corresponding to a lifetime risk by age 80 of 56.1% (95% CI 50.8–61.4%). This evidence concerns the gene PALB2 and breast carcinoma.